Grimes & Company’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-48,173
Closed -$1.6M 217
2017
Q2
$1.6M Sell
48,173
-1,707
-3% -$52.8K 0.18% 92
2017
Q1
$1.6M Buy
49,880
+10,692
+27% +$365K 0.18% 91
2016
Q4
$1.42M Sell
39,188
-683
-2% -$27.3K 0.16% 95
2016
Q3
$1.83M Sell
39,871
-3,653
-8% -$191K 0.25% 85
2016
Q2
$2.19M Sell
43,524
-10,361
-19% -$552K 0.29% 83
2016
Q1
$2.88M Buy
53,885
+7,111
+15% +$417K 0.37% 70
2015
Q4
$3.07M Sell
46,774
-64
-0.1% -$3.96K 0.41% 67
2015
Q3
$2.65M Sell
46,838
-2,551
-5% -$165K 0.34% 74
2015
Q2
$2.92M Buy
49,389
+478
+1% +$29.5K 0.41% 72
2015
Q1
$3.05M Buy
48,911
+1,139
+2% +$66.2K 0.73% 58
2014
Q4
$2.75M Sell
47,772
-2,174
-4% -$121K 0.71% 61
2014
Q3
$2.68M Sell
49,946
-1,182
-2% -$62.6K 0.7% 61
2014
Q2
$2.68M Buy
51,128
+969
+2% +$49.5K 0.7% 60
2014
Q1
$2.65M Buy
50,159
+1,374
+3% +$63.5K 0.74% 55
2013
Q4
$1.96M Sell
48,785
-71,823
-60% -$2.83M 0.58% 60
2013
Q3
$4.56M Buy
120,608
+8,575
+8% +$335K 1.54% 30
2013
Q2
$4.39M Buy
+112,033
New +$4.36M 1.6% 26

Other funds holding TEVA